Physician profile
Joel M Matta
NPI 1982747549
$20,997,562.06
in general payments reported to CMS, 2019-2025
11 companies · $1.5M in 2025
The $1.5M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8.8M · 2020: $2.3M · 2021: $3.0M · 2022: $1.5M · 2023: $1.6M · 2024: $2.2M · 2025: $1.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.7M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500K · Education: $70K · Consulting Fee: $44K · Travel and Lodging: $21K · Food and Beverage: $3,499 · Gift: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,731,121.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500,000.00 |
| Education | $70,125.00 |
| Consulting Fee | $43,742.50 |
| Travel and Lodging | $21,192.33 |
| Food and Beverage | $3,499.04 |
| Gift | $512.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $18,561,002.11 | 2019-2025 | Actis |
| Medical Device Business Services, INC. | $2,247,502.10 | 2019-2025 | Corail, Pinnacle, Reclaim |
| Zimmer Biomet Holdings, INC. | $81,687.44 | 2023-2025 | Avenir, G7, Oxford |
| Medacta USA, INC. | $47,415.81 | 2019-2025 | Must, Quadra |
| Medtronic, INC. | $27,622.62 | 2021-2022 | |
| Medtronic USA, INC. | $24,199.46 | 2019 | |
| Synthes Gmbh | $3,728.40 | 2019 | |
| Smith+Nephew, INC. | $2,882.94 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,359.68 | 2019-2025 | Actis |
| Si-Bone, INC. | $161.50 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,350,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Matta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.